Clinical trial

Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability

NCT02002819

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-10-16

PhasePHASE2

Study timeline

Study start (actual)2014-10-16Date precision: day

Registry last updated2022-05-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

levetiracetamDRUG · verified · RxNorm: levetiracetam

Sponsors & collaborators

University of Minnesotalead sponsor

Mapped research locations

San FranciscoCalifornia, United States1 MinneapolisMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02002819 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.